About Biomatlante
Biomatlante is a company based in France founded in 1995 was acquired by Advanced Medical Solutions in December 2019. Biomatlante has raised $5.1 million across 2 funding rounds from investors including Advanced Medical Solutions. Biomatlante offers products and services including MBCP®, In’Oss™, and EZ Cure™. Biomatlante operates in a competitive market with competitors including Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.
- Headquarter Brittany, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomatlante Sas
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.1 M (USD)
in 2 rounds
-
Latest Funding Round
$286.77 K (USD), Grant
Jan 01, 2017
- Investors
-
Employee Count
Not available
-
Acquired by
Advanced Medical Solutions
(Dec 02, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomatlante
Biomatlante offers a comprehensive portfolio of products and services, including MBCP®, In’Oss™, and EZ Cure™.
Material for bone regeneration in orthopedic surgeries
Injectable solution for enhancing bone repair
Membrane for guided bone regeneration in dental procedures
Funding Insights of Biomatlante
Biomatlante has successfully raised a total of $5.1M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $286.77 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biomatlante
Biomatlante has secured backing from 1 investor. Prominent investors backing the company include Advanced Medical Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wound care products and surgical dressings are developed.
|
Locked | Locked | Locked |
Investor details for Biomatlante
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomatlante
Investment portfolio details for Biomatlante
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biomatlante
Detailed financials for Biomatlante
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomatlante Comparisons
Peer comparison for Biomatlante
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomatlante
Biomatlante operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
Detailed competitors of Biomatlante
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomatlante
Complete news archive for Biomatlante
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomatlante
Biomatlante was founded in 1995 and raised its 1st funding round 14 years after it was founded.
Biomatlante is headquartered in France. It is registered at Brittany, France.
Biomatlante is a funded company, having raised a total of $5.1M across 2 funding rounds to date.
Biomatlante was founded in 1995 in Brittany, France, focusing on biomaterials in the medical device sector. Synthetic bone graft technologies are provided for orthopedic, spine, dental, and sports medicine applications. Solutions include biphasic calcium phosphate products for reconstruction and traumatology, spine fusions in cervical and thoracolumbar regions, dental bone and soft tissue regeneration, and resorbable fixation systems like Osteotwin for sports injuries. MBCP technology emphasizes micromacroporosity and biphasic composition.
Biomatlante's top competitors include EpiBone, Theradaptive and MiMedx Group.
Biomatlante offers MBCP®, In’Oss™, and EZ Cure™.
Biomatlante has 1 investor. Key investors include Advanced Medical Solutions.